Thyrocare Technologies (THYROCARE) — Corporate Action

📢 Key Event
NCLT approves Docon-To-API amalgamation scheme

🔮 What's Next
NCLT order dated August 31, 2026

💡 Investor Takeaway
Promoter holding remains 51.02% but now controlled directly by API

Thyrocare Technologies announced that its wholly owned subsidiary Docon Technologies has been amalgamated with parent API Holdings following approval by the National Company Law Tribunal on August 31, 2026. The scheme becomes effective upon completion of statutory filings, transferring Docon's 8.12 million shares representing 51.02% of Thyrocare's paid-up capital to API Holdings. Post-merger, API will hold the promoter stake directly while the aggregate promoter holding remains unchanged at 51.02%.

📄 View Original Announcement (PDF)

📊 Stock Analysis — THYROCARE ✨ Ask AI About This

About Thyrocare Technologies Ltd (THYROCARE)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹9,402.69 Cr P/E: 34.6 ROE: 34.3% ROCE: 45.6% Div Yield: 1.18%

View full THYROCARE stock details →

📡 Get AI alerts when THYROCARE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track THYROCARE — Free

💡 Ask AI about this filing

"How will the direct promoter stake affect governance?" "What is the valuation impact of this restructuring?" "When will the NCLT order be filed with the Registrar of Companies?"

Ask AI Free →

📊 More THYROCARE filings

See all THYROCARE filings →

🔥 Also filed on 1 September 2026

WHBRADY W H Brady & Co Ltd Annual Report SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement 544083 Shree Marutinandan Tubes Ltd Annual Report SHERVANI Shervani Industrial Syndicate Ltd Corporate Action CORDSCABLE Cords Cable Industries Ltd Annual Report FORTIS Fortis Healthcare Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when THYROCARE files new disclosures

Track THYROCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track THYROCARE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd